This inventor holds 1 USPTO granted patent. Top assignee: Alphavax, Incorporated. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Jeffrey D. Chulay: Innovator in Vaccine Development
Introduction
Jeffrey D. Chulay is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of vaccine development, particularly through his innovative work on cytomegalovirus vaccines.
Latest Patents
Chulay holds a patent for an invention titled "Alpha virus-based cytomegalovirus vaccines." This patent provides methods and compositions that include a population of alphavirus replicon particles. These particles comprise alphavirus replicon RNAs, with one replicon RNA encoding cytomegalovirus pp65 and IE1 protein or immunogenic fragments thereof, while the second replicon RNA encodes cytomegalovirus gB protein or an immunogenic fragment thereof. Each of the two replicon RNAs is contained within a separate alphavirus replicon particle. He has 1 patent to his name.
Career Highlights
Chulay's career has been marked by his dedication to advancing vaccine technology. His work at Alphavax, Incorporated has positioned him as a key player in the development of innovative vaccine solutions.
Collaborations
Throughout his career, Chulay has collaborated with esteemed colleagues, including Sergey A. Dryga and Elizabeth A. Reap. These partnerships have further enhanced his contributions to the field.
Conclusion
Jeffrey D. Chulay's work in vaccine development exemplifies the impact of innovative thinking in addressing public health challenges. His contributions continue to pave the way for advancements in immunization strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile